"Existentialism" is a label first applied in the West, but it can and should rightly be recognized as emerging in various ...

Gina Woods, MD, shares three case scenarios of sequential treatment decision-making for long-term therapy and discusses research that can inform clinical decisions.

Particle therapy experts gathered in London to discuss the transformative potential of laser-driven proton and ion beams ...

Avoid unnecessary tests and antibiotics by applying evidence-based, cost-conscious infectious-disease decision-making, with ...

In the midst of a testosterone replacement surge among younger men, a 62-year-old exercise fanatic shares his thoughts ...

Participants in an IFS PTSD-SUD (substance use disorder) intervention experienced reduced PTSD symptoms and cravings, making it a promising public health treatment option.

For International Women's Day, Dr. Maja Matarić and Dr. Tania Morimoto discussed their current robotics research and student development.

The Howard Center, the Champlain Valley Office of Economic Opportunity, and the Vermont Department of Health have come ...

In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...

In an interview, Vincent Ma, MD, discussed how ctDNA levels after the first cycle of immune checkpoint inhibitor in melanoma ...

Single-trial approvals are raising the bar on trial design and execution. The new paradigm is pushing sponsors to plan earlier, step up their data and risk‑based quality management and use modeling ...